<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    electroCore, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About electroCore, Inc.

    electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The company’s current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $426,000,000
    • SIC CODE
      3845
    • NIN CODE
      ####
    • LEADERSHIP
      Francis R. Amato
    • FOUNDED
      2005
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Fluidigm Corporation

    Fluidigm Corporation

    Fluidigm (NASDAQ:FLDM) is an industry-leading biotechnology tools provider with a ...

    Fluidigm (NASDAQ:FLDM) is an industry-leading b...

    Filing Type:    PU
    Sientra, Inc.

    Sientra, Inc.

    Headquartered in Santa Barbara, California, Sientra is a diversified global medica...

    Headquartered in Santa Barbara, California, Sie...

    Filing Type:    PU
    Spark Therapeutics, Inc.

    Spark Therapeutics, Inc.

    Spark Therapeutics, a fully integrated company, strives to challenge the inevitabi...

    Spark Therapeutics, a fully integrated company,...

    Filing Type:    PU
    Quidel Corporation

    Quidel Corporation

    Quidel Corporation (Nasdaq: QDEL) is a California-based leading manufacturer of di...

    Quidel Corporation (Nasdaq: QDEL) is a Californ...

    Filing Type:    PU
    Surmodics, Inc.

    Surmodics, Inc.

    Following two acquisitions of Creagh Medical and NorMedix – recognized innovator...

    Following two acquisitions of Creagh Medical an...

    Filing Type:    PU
    Biogen Inc.

    Biogen Inc.

    At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers...

    At Biogen, our mission is clear: we are pioneer...

    Filing Type:    PU
    Insitu Biologics, Inc

    Insitu Biologics, Inc

    InSitu Biologics is an emerging biotech company focusing on development of AnestaG...

    InSitu Biologics is an emerging biotech company...

    Amount Raised:    $2,000,000.00
    Fundraising Status:    EC
    Filing Type:    RA
    Recro Pharma, Inc.

    Recro Pharma, Inc.

    Recro Pharma (NASDAQ: REPH) is a revenue generating specialty pharmaceutical compa...

    Recro Pharma (NASDAQ: REPH) is a revenue genera...

    Filing Type:    PU
    Nuvectra Corporation

    Nuvectra Corporation

    NuvectraÂŽ is a neurostimulation company committed to helping physicians improve t...

    NuvectraÂŽ is a neurostimulation company commit...

    Filing Type:    PU
    BioDelivery Sciences International, Inc.

    BioDelivery Sciences International, Inc.

    BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a rapidly growing comme...

    BioDelivery Sciences International, Inc. (NASDA...

    Filing Type:    PU
    CymaBay Therapeutics Inc.

    CymaBay Therapeutics Inc.

    We are a clinical-stage biopharmaceutical company focused on developing and provid...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Chiasma, Inc.

    Chiasma, Inc.

    Chiasma is focused on improving the lives of patients who face challenges associat...

    Chiasma is focused on improving the lives of pa...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.